Finance

Lists
4554:TYO
Fuji Pharma Co Ltd
1 748,00 JP¥
0,00%
(0,00) 1D
8-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4554...
Mkt. cap
45,54 млд
Avg. vol.
101,79 миң
Volume
0,00
Dividend
2,60%
Quarterly dividend
11 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
14,69
52-wk high
2 559 JP¥
52-wk low
1 535 JP¥
EPS
119 JP¥
Shares outstanding
29,92 млн
No. of employees
2 миң
Mkt. cap
45,54 млд
Avg. vol.
101,79 миң
Volume
0,00
Dividend
2,60%
Quarterly dividend
11 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
14,69
52-wk high
2 559 JP¥
52-wk low
1 535 JP¥
EPS
119 JP¥
Shares outstanding
29,92 млн
No. of employees
2 миң
News stories
From web sources and news partners
About Fuji Pharma Co Ltd
CEO-
Employees1,76 миң
Founded1965-ж., 1-апр.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
14,72 млд
15,90 млд
13,82 млд
15,67 млд
Cost of goods sold
8,71 млд
9,08 млд
8,30 млд
10,33 млд
Cost of revenue
8,71 млд
9,08 млд
8,30 млд
10,33 млд
Research and development expenses
3,34 млд
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-428,00 млн
4,03 млд
3,90 млд
4,34 млд
Operating expense
4,39 млд
4,03 млд
3,90 млд
4,34 млд
Total operating expenses
13,10 млд
13,11 млд
12,21 млд
14,67 млд
Operating income
1,62 млд
2,79 млд
1,61 млд
995,00 млн
Other non operating income
68,00 млн
-47,00 млн
139,00 млн
222,00 млн
EBT including unusual items
1,30 млд
195,00 млн
489,00 млн
1,43 млд
EBT excluding unusual items
1,63 млд
2,65 млд
1,68 млд
1,22 млд
Income tax expense
133,00 млн
-129,00 млн
100,00 млн
320,00 млн
Effective tax rate
10,21%
-66,15%
20,45%
22,42%
Other operating expenses
-
-
-
-
Net income
1,17 млд
324,00 млн
389,00 млн
1,11 млд
Net profit margin
7,95%
2,04%
2,81%
7,07%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,00 млн
1,00 млн
Interest expense
-100,00 млн
-84,00 млн
-105,00 млн
-98,00 млн
Net interest expenses
-100,00 млн
-84,00 млн
-104,00 млн
-97,00 млн
Depreciation and amortization charges
1,38 млд
-
-
-
EBITDA
2,61 млд
3,78 млд
2,64 млд
1,99 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору